Key result
In high-altitude residents with hypoxic pulmonary hypertension, elevated LPa strongly predicted mortality (HR 3.461; 95% CI 2.021-5.928; P<0.001), alongside atrial fibrillation and alcohol use.
Why the study?
Hypobaric hypoxia at high altitude increases the risk of hypoxic pulmonary hypertension (HPH), but risk factors and mortality predictors in this population are not well characterized.
Cohort (n=627)
No
Hazard Ratio: 3.461 (95% CI 2.021–5.928)
p-value: p=<0.001
In high-altitude residents with hypoxic pulmonary hypertension, elevated LPa, atrial fibrillation, heart failure, and alcohol consumption are significant independent predictors of mortality.
May guide risk stratification for high-altitude HPH; leaves open whether identified factors improve outcomes without prospective validation.
Background: Over 80 million people reside above 2,500 meters, where hypobaric hypoxia elevates the risk of hypoxic pulmonary hypertension (HPH). In Qinghai, China (>3,000 m), over 5 million face a high HPH burden amid scarce medical resources. Objective: To assess risk factors and clinical correlates of HPH severity and mortality in high-altitude residents using echocardiography. Methods: This retrospective study included 627 patients diagnosed with HPH (PASP ≥50 mmHg) via echocardiography at a tertiary hospital in Qinghai Province, China, from January 2018 to December 2022. Patients were categorized into moderate (50 ≤ PASP < 70 mmHg) and severe (PASP ≥70 mmHg) HPH groups. Clinical, biochemical, and echocardiographic data were collected, with mortality assessed via telephone follow-up after at least one year. Logistic regression identified factors associated with severe HPH, and Cox regression determined mortality predictors. Results: Of the 627 patients, 360 (57.4%) had moderate HPH and 267 (42.6%) had severe HPH. The severe HPH group exhibited lower albumin (33.50 ± 5.54 g/L vs. 35.45 ± 6.65 g/L, p < 0.001) and higher APTT (34.04 ± 7.48 s vs. 31.44 ± 6.91 s, p < 0.001), LPa (142.27 ± 126.64 mg/L vs. 110.67 ± 101.01 mg/L, p = 0.001), and rates of heart failure, cyanosis, and right ventricular hypertrophy (all p < 0.05). Logistic regression identified APTT (OR = 1.050, 95% CI: 1.014–1.087, p = 0.007), LPa (OR = 1.002, 95% CI: 1.001–1.004, p = 0.003), cyanosis (OR = 1.814, 95% CI: 1.235–2.663, p = 0.002), and right ventricular hypertrophy (OR = 3.501, 95% CI: 1.631–7.514, p = 0.001) as factors associated with severe HPH. Multivariate Cox regression identified LPa (HR = 3.461, 95% CI: 2.021–5.928, p < 0.001), atrial fibrillation (HR = 2.534, 95% CI: 1.365–4.705, p = 0.003), heart failure (HR = 2.316, 95% CI: 1.134–4.730, p = 0.021), and alcohol consumption (HR = 3.230, 95% CI: 1.277–8.171, p = 0.013) as mortality predictors. Conclusion: In high-altitude Qinghai residents, APTT, LPa, cyanosis, and right ventricular hypertrophy drive severe HPH, while LPa, atrial fibrillation, heart failure, and alcohol use predict mortality. Monitoring APTT and LPa may aid early detection, and managing modifiable factors like alcohol and atrial fibrillation could lower mortality in resource-limited settings.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2026) conducted a cohort in Hypoxic pulmonary hypertension (HPH) (n=627). Elevated LPa vs. Lower LPa was evaluated on Mortality (HR 3.461, 95% CI 2.021-5.928, p=<0.001). In high-altitude residents with hypoxic pulmonary hypertension, elevated LPa strongly predicted mortality (HR 3.461; 95% CI 2.021-5.928; P<0.001), alongside atrial fibrillation and alcohol use.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: